connect with us
.
�we have waited a long time and we cannot possibly wait any longer.�
.
despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6.
.
.
copyright © 2018 the daily californian, the independent berkeley student publishing co., inc.
.
.
.